COO vs. WST, ALGN, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.
Cooper Companies vs.
Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.
Cooper Companies received 354 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 66.38% of users gave Cooper Companies an outperform vote while only 56.20% of users gave West Pharmaceutical Services an outperform vote.
Cooper Companies presently has a consensus price target of $110.25, indicating a potential upside of 37.61%. West Pharmaceutical Services has a consensus price target of $332.50, indicating a potential upside of 57.20%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.
24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 2.0% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Cooper Companies and Cooper Companies both had 35 articles in the media. Cooper Companies' average media sentiment score of 0.94 beat West Pharmaceutical Services' score of 0.32 indicating that Cooper Companies is being referred to more favorably in the media.
West Pharmaceutical Services has a net margin of 17.03% compared to Cooper Companies' net margin of 10.07%. West Pharmaceutical Services' return on equity of 18.60% beat Cooper Companies' return on equity.
Cooper Companies has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500.
West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Summary
West Pharmaceutical Services beats Cooper Companies on 11 of the 18 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
This page (NASDAQ:COO) was last updated on 5/29/2025 by MarketBeat.com Staff
Buy COO Stock Free COO Stock Alerts